Tuuminen, Raimo <br/><br/>
Dual antiplatelet and anticoagulant APAC prevents experimental ischemia-reperfusion-induced acute kidney injury.  [electronic resource] 

 -  Clinical and experimental nephrology  Jun 2017 
 - 436-445 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1437-7799 
<br/><br/><label>Standard No.: </label>10.1007/s10157-016-1308-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Kidney Injury--blood<br/>Acute-Phase Proteins<br/>Angiopoietin-2--blood<br/>Animals<br/>Anticoagulants--pharmacokinetics<br/>Biomarkers--blood<br/>Biotransformation<br/>Blood Coagulation--drug effects<br/>Blood Urea Nitrogen<br/>Creatinine--blood<br/>Disease Models, Animal<br/>Drug Therapy, Combination<br/>Heparin--analogs & derivatives<br/>Hyaluronic Acid--blood<br/>Immunity, Innate--drug effects<br/>Kidney--drug effects<br/>Lipocalin-2<br/>Lipocalins--blood<br/>Male<br/>Partial Thromboplastin Time<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--pharmacokinetics<br/>Platelet Function Tests<br/>Positron Emission Tomography Computed Tomography<br/>Proteoglycans--pharmacokinetics<br/>Prothrombin Time<br/>Proto-Oncogene Proteins--blood<br/>Rats, Sprague-Dawley<br/>Reperfusion Injury--blood<br/>Syndecan-1--blood<br/>Tissue Distribution